Reporting of Abnormal Behaviour of Radiopharmaceuticals Update
We have had some queries from members about reporting abnormal behaviour with radiopharmaceuticals, however the Society no longer maintains a register for these occurrences. The reporting of these should be undertaken within your organisation's reporting processes including local (state/national) laws as appropriate.
The Society's Radiopharmacy group, led by A/Prof Giancarlo Pascali, is reviewing ways and means whereby feedback and deidentified data can be gathered from the members. This info may allow to determine patterns or issues that are not of a regulatory nature, but could still serve in improving the reliability and safety of radiopharmaceuticals by interfacing with key stakeholders.